SEC Form 3 · accession 0001739940-26-000053
Cigna Group · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Perlberg
Officer — See Remarks
Period of report
Jul 1, 2026
Accepted (ET)
Jul 9, 2026 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | holding | — | — | — | 9,345 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $227.02 | holding | — | — | — | Mar 1, 2023 | Feb 23, 2032 | Common Stock, $.01 Par Value | 791 | — | D |
| Employee Stock Option (Right to Buy)F2 | $294.61 | holding | — | — | — | Mar 1, 2024 | Feb 22, 2033 | Common Stock, $.01 Par Value | 3,136 | — | D |
| Employee Stock Option (Right to Buy)F3 | $336.475 | holding | — | — | — | Mar 1, 2025 | Feb 28, 2034 | Common Stock, $.01 Par Value | 5,658 | — | D |
| Employee Stock Option (Right to Buy)F4 | $305.855 | holding | — | — | — | Mar 1, 2026 | Feb 28, 2035 | Common Stock, $.01 Par Value | 6,343 | — | D |
| Employee Stock Option (Right to Buy)F5 | $287.5475 | holding | — | — | — | Mar 1, 2027 | Feb 27, 2036 | Common Stock, $.01 Par Value | 4,643 | — | D |
Explanation of responses
- F1This option vested in three equal annual installments beginning March 1, 2023.
- F2This option vested in three equal annual installments beginning March 1, 2024.
- F3This option vests in three equal annual installments beginning March 1, 2025.
- F4This option vests in three equal annual installments beginning March 1, 2026.
- F5This option vests in three equal annual installments beginning March 1, 2027.
Remarks
Title - President, Evernorth Pharmacy & Care Delivery and EVP, Customer Innovation / EX-24 Power of Attorney